CXCL8 and prostate carcinoma: It is noteworthy that no significant CXCL8 immunoreactivity was detected in the CRC tissue, despite using similar approaches that were previously successful in assessing CXCL8 expression in prostate cancer epithelium (Murphy et al, 2005).